Role of ALDH2 in Hepatic Disorders: Gene Polymorphism and Disease Pathogenesis

J Clin Transl Hepatol. 2021 Feb 28;9(1):90-98. doi: 10.14218/JCTH.2020.00104. Epub 2021 Jan 4.


Aldehyde dehydrogenase 2 (ALDH2) is a key enzyme of alcohol metabolism and it is involved in the cellular mechanism of alcohol liver disease. ALDH2 gene mutations exist in about 8% of the world's population, with the incidence reaching 45% in East Asia. The mutations will result in impairment of enzyme activity and accumulation of acetaldehyde, facilitating the progression of other liver diseases, including non-alcoholic fatty liver diseases, viral hepatitis and hepatocellular carcinoma, through adduct formation and inflammatory responses. In this review, we seek to summarize recent research progress on the correlation between ALDH2 gene polymorphism and multiple liver diseases, with an attempt to provide clues for better understanding of the disease mechanism and for strategy making.

Keywords: Alcoholic liver disease; Aldehyde dehydrogenase 2; Gene polymorphisms; Hepatocellular carcinoma; Non-alcoholic fatty liver disease; Viral hepatitis.

Publication types

  • Review